JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $5,668,039 | -52.6% | 5,106,341 | 0.0% | 0.12% | -57.8% |
| Q3 2022 | $11,949,000 | -9.5% | 5,106,341 | +17.2% | 0.28% | -19.4% |
| Q2 2022 | $13,206,000 | -58.4% | 4,358,433 | -6.9% | 0.34% | -48.2% |
| Q1 2022 | $31,780,000 | +32.9% | 4,680,412 | +63.5% | 0.66% | +88.5% |
| Q4 2021 | $23,908,000 | +130.5% | 2,863,198 | +105.1% | 0.35% | +123.7% |
| Q3 2021 | $10,374,000 | – | 1,396,203 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 1,347,829 | $9,152,000 | 93.42% |
| Ally Bridge Group (NY) LLC | 550,000 | $3,735,000 | 2.77% |
| ACUTA CAPITAL PARTNERS, LLC | 813,500 | $5,524,000 | 2.58% |
| TRV GP III, LLC | 1,148,780 | $7,800,000 | 2.12% |
| Deep Track Capital, LP | 4,259,653 | $28,923,000 | 1.86% |
| Logos Global Management LP | 1,400,000 | $9,506,000 | 1.23% |
| PFM Health Sciences, LP | 3,972,868 | $26,976,000 | 1.01% |
| Sofinnova Investments, Inc. | 1,481,219 | $10,057,000 | 0.76% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 248,347 | $1,686,000 | 0.70% |
| RTW INVESTMENTS, LP | 4,680,412 | $31,780,000 | 0.66% |